A review on cholinesterase inhibitors for Alzheimer's disease

P Anand, B Singh - Archives of pharmacal research, 2013 - Springer
Abstract Alzheimer's disease (AD), a progressive neurodegenerative disorder, is
characterized by the deficits in the cholinergic system and deposition of beta amyloid (Aβ) in …

Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection

M Singh, M Kaur, H Kukreja, R Chugh, O Silakari… - European journal of …, 2013 - Elsevier
Acetylcholinesterase is a member of the α/β hydrolase protein super family, with a significant
role in acetylcholine-mediated neurotransmission. Research in the modulators of AChEs …

Benzofuran and indole: promising scaffolds for drug development in Alzheimer's disease

D Goyal, A Kaur, B Goyal - ChemMedChem, 2018 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The Food and Drug Administration has …

Recent insight into the biological activities of synthetic xanthone derivatives

I Ahmad - European journal of medicinal chemistry, 2016 - Elsevier
Xanthones are a class of oxygen containing heterocyclic compounds with a broad range of
biological activities, and they have prominent significance in the field of medicinal chemistry …

The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies

SH Lu, JW Wu, HL Liu, JH Zhao, KT Liu… - Journal of Biomedical …, 2011 - Springer
Background Alzheimer's disease (AD) is the most common cause of dementia characterized
by progressive cognitive impairment in the elderly people. The most dramatic abnormalities …

Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment

A Musial, M Bajda, B Malawska - Current medicinal chemistry, 2007 - ingentaconnect.com
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central
nervous system (CNS) which is the most common cause of dementia in the elderly. It is …

Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, β amyloid aggregation, and Aβ neurotoxicity

S Rizzo, C Rivière, L Piazzi, A Bisi… - Journal of medicinal …, 2008 - ACS Publications
The complex etiology of Alzheimer's disease (AD) prompts scientists to develop multitarget
strategies to combat causes and symptoms. We therefore designed, synthesized, and tested …

Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease

ML Bolognesi, R Banzi, M Bartolini… - Journal of medicinal …, 2007 - ACS Publications
One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective
disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent …

Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases

R Farina, L Pisani, M Catto, O Nicolotti… - Journal of medicinal …, 2015 - ACS Publications
The multifactorial nature of Alzheimer's disease calls for the development of multitarget
agents addressing key pathogenic processes. To this end, by following a docking-assisted …

Cascade-reaction-based nanodrug for combined chemo/starvation/chemodynamic therapy against multidrug-resistant tumors

Y Chen, Y Yao, X Zhou, C Liao, X Dai… - … applied materials & …, 2019 - ACS Publications
We report a chemo/starvation/chemodynamic trimodal combination therapy to combat
multidrug-resistant (MDR) tumors by developing a ferrocene-containing nanovesicle (FcNV) …